Product Information
GNP PAIN RLF PM 250-250-38 MG is a generic product labeled by AmerisourceBergen, priced at $0.0598 per EA under NDC 46122045671. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
250; 250; 38 mg/1; mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122045671
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
8/31/2016
Pharmacological Classes
Price Statistics
The NADAC for GNP PAIN RLF PM 250-250-38 MG has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0598 per EA |
|---|---|
| All-time high | $0.0608 (May 15, 2024) |
| All-time low | $0.0538 (Sep 18, 2024) |
| 52-week high | $0.0598 |
| 52-week low | $0.0598 |
| Median price | $0.0598 |
| Average price | $0.0583 |
| Largest weekly change | -4.9% (Aug 21, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Acetaminophen, Aspirin, Diphenhydramine citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GNP PAIN RLF PM 250-250-38 MG?
The current National Average Drug Acquisition Cost (NADAC) for GNP PAIN RLF PM 250-250-38 MG, manufactured by AmerisourceBergen, is $0.0598 per EA (NDC 46122045671), effective Jun 24, 2026.
How has the price of GNP PAIN RLF PM 250-250-38 MG changed over time?
Over the history we have for it, the NADAC for GNP PAIN RLF PM 250-250-38 MG has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GNP PAIN RLF PM 250-250-38 MG?
Since Apr 17, 2024, the NADAC for GNP PAIN RLF PM 250-250-38 MG has ranged from a low of $0.0538 (Sep 18, 2024) to a high of $0.0608 (May 15, 2024), with a median of $0.0598 per EA.
Are there cheaper alternatives to GNP PAIN RLF PM 250-250-38 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GNP PAIN RLF PM 250-250-38 MG, so no direct lower-cost alternative is listed.
Who manufactures GNP PAIN RLF PM 250-250-38 MG?
GNP PAIN RLF PM 250-250-38 MG (NDC 46122045671) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.
Related Drugs
Same classification